BioAdaptives Announces Initial Investigation Results on Pluripain
24 Feb 2022 //
GLOBENEWSWIRE
Gadolinium-based contrast agents: update from Guerbet LLC on U.S. FDA
27 Dec 2017 //
PR NEWSWIRE
EMA’s PRAC Seeks to Suspend Four Imaging Agents
17 Mar 2017 //
RAPS
Celgene Announces Positive Phase 3 Study Results for MS Drug Ozanimod
17 Feb 2017 //
DDDMAG